A study comparing COVID-19 ARDS patients with ARDS due to other causes showed that the PTEN signaling pathway is activated in COVID-19 ARDS patients (Sarma et al., 2021) and plays an antiviral role as an immunomodulator (Chen and Guo, 2017). This evidence concerns the gene PTEN and acute respiratory distress syndrome.